GB2066076A - Sterilizing with gas plasmas and aldehydes - Google Patents
Sterilizing with gas plasmas and aldehydes Download PDFInfo
- Publication number
- GB2066076A GB2066076A GB8000096A GB8000096A GB2066076A GB 2066076 A GB2066076 A GB 2066076A GB 8000096 A GB8000096 A GB 8000096A GB 8000096 A GB8000096 A GB 8000096A GB 2066076 A GB2066076 A GB 2066076A
- Authority
- GB
- United Kingdom
- Prior art keywords
- gas plasma
- gas
- aldehyde
- plasma
- sterilizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001299 aldehydes Chemical class 0.000 title claims abstract description 74
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 34
- 210000002381 plasma Anatomy 0.000 title description 63
- 238000000034 method Methods 0.000 claims abstract description 40
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 125000003118 aryl group Chemical group 0.000 claims abstract description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 4
- 239000007789 gas Substances 0.000 claims description 104
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000012159 carrier gas Substances 0.000 claims description 16
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 14
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 claims description 12
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 claims description 12
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 12
- -1 unsaturated acyclic aldehyde Chemical class 0.000 claims description 10
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 9
- PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical compound O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 claims description 7
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 7
- 229910052753 mercury Inorganic materials 0.000 claims description 7
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 7
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 claims description 7
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 claims description 6
- 229940015043 glyoxal Drugs 0.000 claims description 6
- MLUCVPSAIODCQM-NSCUHMNNSA-N crotonaldehyde Chemical compound C\C=C\C=O MLUCVPSAIODCQM-NSCUHMNNSA-N 0.000 claims description 5
- MLUCVPSAIODCQM-UHFFFAOYSA-N crotonaldehyde Natural products CC=CC=O MLUCVPSAIODCQM-UHFFFAOYSA-N 0.000 claims description 5
- 230000005284 excitation Effects 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- WWMIMRADNBGDHP-UHFFFAOYSA-N 2-hydroxyhexanedial Chemical compound O=CC(O)CCCC=O WWMIMRADNBGDHP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 claims description 2
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
- 239000001307 helium Substances 0.000 claims description 2
- 229910052734 helium Inorganic materials 0.000 claims description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 claims description 2
- 150000002830 nitrogen compounds Chemical class 0.000 claims description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 3
- 239000003139 biocide Substances 0.000 claims 3
- 125000002015 acyclic group Chemical group 0.000 claims 1
- 230000005672 electromagnetic field Effects 0.000 claims 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical group O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- 150000002898 organic sulfur compounds Chemical class 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
- 230000002147 killing effect Effects 0.000 abstract description 15
- 150000002500 ions Chemical class 0.000 abstract description 5
- 230000007935 neutral effect Effects 0.000 abstract description 3
- 229920006395 saturated elastomer Polymers 0.000 abstract description 3
- 238000012414 sterilization procedure Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000004743 Polypropylene Substances 0.000 description 295
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 74
- 210000004215 spore Anatomy 0.000 description 25
- 235000019256 formaldehyde Nutrition 0.000 description 24
- 238000012545 processing Methods 0.000 description 22
- 235000014469 Bacillus subtilis Nutrition 0.000 description 18
- 208000028659 discharge Diseases 0.000 description 15
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000003330 sporicidal effect Effects 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 10
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 8
- 229960000587 glutaral Drugs 0.000 description 8
- 244000005700 microbiome Species 0.000 description 7
- 230000001590 oxidative effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000009792 diffusion process Methods 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 108010013639 Peptidoglycan Proteins 0.000 description 5
- GWVKDXOHXJEUCP-UHFFFAOYSA-N [N].[O].[Ar] Chemical compound [N].[O].[Ar] GWVKDXOHXJEUCP-UHFFFAOYSA-N 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 238000005273 aeration Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 210000001938 protoplast Anatomy 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000002360 explosive Substances 0.000 description 3
- 239000002316 fumigant Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920002492 poly(sulfone) Polymers 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000004666 bacterial spore Anatomy 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229960005419 nitrogen Drugs 0.000 description 2
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000272470 Circus Species 0.000 description 1
- 241000193470 Clostridium sporogenes Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000654838 Exosporium Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000005276 aerator Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- HRQGCQVOJVTVLU-UHFFFAOYSA-N bis(chloromethyl) ether Chemical compound ClCOCCl HRQGCQVOJVTVLU-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- 239000002800 charge carrier Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000011796 hollow space material Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- JWZXKXIUSSIAMR-UHFFFAOYSA-N methylene bis(thiocyanate) Chemical compound N#CSCSC#N JWZXKXIUSSIAMR-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Natural products NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 1
- GAAKLDANOSASAM-UHFFFAOYSA-N undec-10-enoic acid;zinc Chemical compound [Zn].OC(=O)CCCCCCCCC=C GAAKLDANOSASAM-UHFFFAOYSA-N 0.000 description 1
- 239000012808 vapor phase Substances 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940118257 zinc undecylenate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/14—Plasma, i.e. ionised gases
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Plasma & Fusion (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
Sterilization of the surfaces of objects is achieved by placing the same in a continuous flow of a low temperature, low pressure gas plasma, containing small amounts of aromatic, heterocyclic, saturated or unsaturated aldehydes alone or mixtures thereof. The gas plasma is a partially ionized gas composed of ions, electrons and neutral species, which may be formed by electromagnetic discharges at subatmospheric pressure in the 1 to 300,000 Megahertz range, and corresponds to a minimum average spatial energy density of 0.001 watts per cubic centimeter. The gas plasma may also contain other vaporized cidal agents. Contrary to most gaseous sterilization procedures, the method is safe, allows quick handling of heat sensitive items, does not corrode equipment and does not leave toxic residues.
Description
SPECIFICATION
Seeded gas plasma sterilization method
This invention relates to gaseous sterilization by the treatment of objects or materials with a chemical
in the gaseous or vapor state to destroy all microor
ganisms with which they have been contaminated.
The need for such a method of sterilization has
developed from the use of many items that cannot
be subjected to heat, radiation, or liquid chemical sterilization.
In practice, onlytwo gases or vapors have been commercially used on a large scale for surface sterilizing purposes and these are formaldehyde vapors and ethylene oxides gas. However, each suffer from drawbacks.
Formaldehyde vapors have been used as a fumigant for many decades in the hospital, agricultural and industrial fields. The limitations of this technique are numerous. To kill tough aerobic and anaerobic bacterial spores at room temperature, one needs at least a 24 hour contact time with a vapor having at least 70% relative humidity. This type of vapor is extremely corrosive and the fumes are very irritating. It is also very difficult to maintain a high level of formaldehyde gas since CH2O is stable in high concentrations only at temperatures above 80"C in humid air. At ordinary room temperatures formaldehyde gas quickly polymerizes and it dissolves readily in the presence of water.Thus gaseous sterilization with formaldehyde can be regarded as a misnomer because introduction of formaldehyde gas into a closed space serves mainly as a mechanism for distributing either moisture films in which formaldehyde is dissolved or solid formaldehyde polymers over all available surfaces within the enclosed space. Very inconsistent and sometimes contradictory results have been reported in hospital disinfection, patient rooms, bedding, etc., and in agricultural applications such as eggs and hatcheries sanitizing. Formaldehyde vapor has a very weak penetrating ability and, if used in an atmosphere with traces of hydrochloric acid, it can quickly produce at 70"C and 40% relative humidity) bis (chloromethyl) - ether, which is a carcinogenic agent.
To minimize the abovementioned drawbacks in hospital applications, a new approach was recently developed which combines the use of subatmospheric steam and formaldehyde gas at 80"C in autoclaves. This method is said to kill most sporulated microorganisms at the concentration normally encountered in hospital practice while decreasing the aldehyde residue on instruments. It requires a time exposure of two hours with a formalin concentration of 8 gr. per cubic foot of autoclave. However, despite the long contact time and the relatively high temperature, the method does not satisfy the stringent requirements of the sporicidal AOAC (Association of Official Analytical Chemists) test in the United
States of America.
From the foregoing, it is apparent that formaldehyde vapors, besides their toxicity and irritating characteristics, are difficult to handle at room temperatures and they do not provide a fast and reliable method to satisfactorily handle most of the hospital and industrial applications.
In the past two decades ethylene oxide (ETO) has become the most popular method to gas sterilize both in hospitals and industry. While initially ETO seemed an ideal technique to replace formaldehyde fumigants, very serious limitations from the toxicity viewpoint have recently attracted the attention of health authorities.
The average time needed to sterilize medical instruments in an ETO unit is 180 minutes at 30"C., but it has to be followed by a long de-aeration period. For instance, the de-aeration time for medical devices is between 2 and 8 hours in a de-aerator machine, but it oscillates between 1 and 8 days at room temperature. On rubber gloves, the residues can burn the hands; on tubes carrying blood, they will damage red blood cells and cause hemolysis.
Endotracheal tubes which are not properly aerated can cause tracheitis or tissue necrosis.
Besides the risks due to the toxicity of ETO residues, other accidents have been reported due to the explosive characteristics of pure ETO. As little as 3% ethylene oxide vapor in air will support combustion and will have explosive violence if confined. To solve this problem, various diluent gases such as CO2orfluorinated hydrocarbons have been mixed with ETO in some commercial formulations.
It is apparent, therefore, that ETO sterilization became widely used not because it was an ideal sterilant, but rather since there seemed to be no alternative gas sterilant method which was capable of as fast a sporicidal action without any drawbacks from the toxicological or environmental viewpoint.
The present invention provides an alternative to
ETO sterilization with the advantages of faster sporicidal action, no de-aeration period, no toxic residue, and no explosion risk. Moreover, this invention provides a more economical approach from the running and investment cost viewpoint when comparing the volume of material treated per unit of time.
In accordance with the present invention, there is provided a method of sterilizing a surface comprising contacting the surface with a low temperature gas plasma containing at least 10 mg/l of an aldehyde under a subatmospheric pressure.
The term "Sterilization" as used herein refers to sporicidal action againstBaclllussubtll!s ATCC (American Type Culture Collection) 19659 and Clostridium sporogenes (ATCC 3584) because they are the resistant microorganisms used in the fumigantsterilant test according to the requirements of the
AOAC (Official Method of Analysis of the Association of Official Analytical Chemists, 12th ed., Nov. 1975).
The destruction of these two resistant species of spores by the AOAC procedure automatically to the destruction of other less resistant microorganisms, such as, mycobacteria, non-lipid and small viruses, lipid and medium size viruses, and vegetative bac teria.
A better understanding of the cidal mechanism of a low temperature gas plasma in accordance with this invention may be had by consideration of the physical structure of a highly resistant spore. Figure 1 represents the typical structure of a typical bacterial spore. The typical bacteria spore is surrounded by an exosporium which is a loose sac peculiarto some spores species, and possesses, from the outside to the inside, successively, (a) multi-layered coats containing disulphide (-S-S-) rich proteins, (b) a thick cortex layer which contains the polymer murein (or peptidoglycan), (c) a plasma membrane, and (d) a core or spore protoplast.
The first line of resistance of the spore to exogenous agents consists of the proteinaceous outer coats which contain keratin-like proteins. The stability of keratin structures is due to frequent primary valence cross links (disulphide bonds) and secondaryvalence cross links (hydrogen bonds) between neighboring polypeptide chains. Keratin-like proteins are typically strong, insoluble in aqueous salt solutions or in diluted acid and basic solutions, and are resistans to proteolytic enzymes and hydrolysis. The layered outer coats, thus, are rather inert and play a predominant role in protecting the spore against exogenous agents. They seem to play an important role in cidal action through physical or chemical modifications which affect the diffusion of cidal molecules, excited atoms or radicals inside the microorganism protoplast.
To alterthe multilayered outer coats and thus allow further penetration and possible interactions in the critical cortex or protoplast regions, a very active agent must be chosen, and it has been found that an ionized gas plasma is an excellent vehicle to provide reactive atoms, free radicals, and molecules which will drastically alterthe protective layers of bacterial, fungi, and spores. The presence of small amounts of aldehyde vapors in the ionized low temperature non-oxidizing gas plasma, in accordance with this invention, leads to the destruction of sporulated and non-sporulated microorganisms.
In the present invention, the objects to be decomtaminated are exposed to a continuous flow of low temperature gas plasma seeded with a small amount of an aldehyde, usually an aromatic, heterocyclic, saturated or unsaturated aldehyde. The gas plasma is a partially ionized gas composed of ions, electrons, and neutral species.
The lowtemperature gas plasma is formed by gaseous electric discharges. In an electrical discharge, free electrons gain energy from the imposed electric field and lose this energy through collisions with neutral gas molecules. The energytransfer process leads to the formation of a variety of highly
reactive products including metastable atoms, free
radicals, and ions.
For an ionized gas produced in an electrical dis
charge to be properly termed a "plasma", it must
satisfy the requirement that the concentrations of
positive and negative charge carriers are approxi
mately equal. The plasma used in the present inven
tion are glow discharges plasma and are also termed
"low temperature" gas plasma. This type of plasma is characterized by average electron energies of 1 to 10 eV and electron densities of 10 9 to 1012 per cm3.
Contrary to the conditions found in arcs or plasma jets, the electron and gas temperatures are very different due to the lack ofthermal equilibrium In a glow discharge, the electron temperature can be ten to a hundred times higher than the gas temperature.
The latter prnpertyisimportantwhen sterilizirrgthe surfaces of thermalrysensitive materials.
In the low temperature gas plasma used in this invention, there can be distinguished two types of reactive elements, i.e < those which consist of atoms, ions or free radicals and those which are small high energy particles such as electrnns and photons. Irr glow discharges a large amount of ultraviolet radiation (UV) is always present. The UV high energy photons (3.3 to 6.2 eV) will produce strong cidal effects because they correspond to a maximum of absorption by DNA (deoxyribonucleic acid) and othernucleic acids. However, in the case of spores which can reach one millimeter in diameter, photon energy can be quickly dissipated through the various spore layers and this may restrict photochemical reactions to outer coats.The photon energy is rather restricted to thin layer surface modifications and is, therefore, more efficacious when dealing with the smaller non-sporulated bacteria. In the case of high resistance spores, the photonic action may contri butt two partial alteration of the disulphide rich proteins coat and thus facilitate the diffusion of free redicals, atoms, or excited molecules inside the core region.
In the present invention, small amounts of vaporized aldehyde monomers and free radicals present in a low temperature gas plasma can greatly increase the overall biocidal action of a gas plasma.
The exact mechanism whereby enhanced sporicidal activity is attained using the aldehyde-seeded plasma stream is not fully understood, but some mechanisms can be considered. For example, due to the presence of atomic or excited oxygen in the gas phase, the aldehydes may produce short life very reactive epoxides and other intermediates and free radicals which may interact with many proteins and nucleic acids groups in outer layer coats and thereby improve diffusion of cidal groups.
The next possible step in the diffusion of cidal groupsisthe penetration inside the cortex layer whose major component is the polymer murein (or peptidoglycan). Murein is a large, crosslinked, netlike molecule. A conjugated attack by atomic oxygen and aldehyde radicals on the polymer rapidly shakes and modifies the tight polymer structure of the cortex layer, leading to its destruction.
In addition, there is the potential for alteration of the hypothetical pathway of dipicolinic acid synthesis by the aldehydes It has long been speculated that since calcium and dipicolinic acid (DPA) occur in spores in roughly equimolar amounts, they form a .
salt complex whose role is capital in spores resistance. The exact location of the calcium salt in
spores is a problem which remains to be solved. The
fast access of aldehydes into the cortex, mainly a
result of gas plasma oxidation, may help blocking
the amine groups of the aspartic p-semialdehyde thus interfering directly with the DPA synthesis.
The latter mechanism may explain why short exposures to a plasma gas in the presence of aldehydes can quickly destroy spores of their germinating capabilities. The aldehydes seeding method of the present invention results in a shorter contact time in gas plasma to achieve a sporicidal effect, as compared with other gaseous phase sterilization procedures.
The cidal action of the low temperature aldehyde seeded gas plasma is so fast sometimes, for example, less than ten minutes, that the possibility of inducing reactions inside the core or protoplast is rather small. The central portion of the spore is functionally a vegetative bud, which contains the heriditary charter, a repressed protein synthesizing system, the enzymes necessary to initiate the synthesis of new enzymes and structurai materials, and, presumably, reserves for the supply of energy intermediates. The modifications taking place in the outer coats, cortex and plasma membranes are sufficient to fully explain the cidal results obtained with the present invention. References above to the oxidation phenomena in a gas plasma are not restricted to the use of pure oxygen as an ionized gas but also includes the use of oxygen-containing gases like air, carbon dioxide and N2O.Although not as fast as oxidizing plasmas, a noble gas, such as argon or helium, or nitrogen plasmas, can be seeded with aldehydes to decrease sterilization time.
The present invention, therefore, enables a considerable reduction in spore killing time to be achieved over the values observed in conventional oxidizing and non-oxidizing gas plasmas. While excited ions, gas molecules, and photons modify the protective layers of the spores, active aldehyde radicals penetrate the changing structures and initiate many additional lethal reactions which accelerate the killing process. A faster surface sterilization time results in a more economical process and provides the possibility to handle many highly heat sensitive materials, which may be degraded by prolonged exposure to the gas plasma, even at high temperatures below 100"C. No severe corrosive or toxic residuals are observed when adding aldehydes to a gas plasma.
To produce a gas plasma of the type required in the present invention, the carrier gas may be excited by one of two different radio-frequency methods.
The first approach consists of a ring type or inductive discharge technique, while the second method consists of a parallel plate or capacitive discharge technique. The processing area consists always of a glass, plastic, or aluminum chamber maintained under subatmospheric pressure, generally 0.1 to 10 mm. of mercury, into which a controlled flow of gas and aldehyde vapor is constantly moving under the continuous suction of a vacuum pump. To excite gases and vapors in the processing area, the radiofrequency energy delivered by a generator is coupled through an inductive coil wrapped around the processing chamber or by means of capacitive discharge plates placed outside the chamber or chamber entrances. While in operation, the RF (radio frequency) discharge glow can be made to extend virtually throughout the entire processing chamber.
In some instances, the electrodes may be positioned in the processing chamber.
There are many ways to design electronic circuitry for maximizing RF energy coupling into the discharging gas. Energy coupling optimization, which can reach up to 90%, can be achieved by matching the gas load impedance to the impedance of the amplifier plate output circuit and the tank coil. The best impedance matching is achieved by a tuning process which consists of adjusting variable condensers in a low impedance matching network connected by coaxial cables between the reactor chamber and the generator. In more modern designs, the processing chamber and the relatively low power generator are coupled directly through high impedance connectors. This eliminates the complicated low impedance network and simplifies the electronic package. During power coupling to the gas plasma, a small amount of power is always lost due to heating effects.There is also an amount of power reflected back to the generator. To know how efficiently one is discharging energy in the gas, a RF wattmeter is often inserted in the electronic circu it to monitor the difference between forward and reflected power.
Gas plasma generators operate generally around 13.5 Megahertz (MHz) but frequencies in the range of 1 to 30 MHz also are satisfactory, and even may range upto 100 MHz.
The gas plasma may also be formed at higherfre- quencies in the microwave region, with frequencies ranging from 100 to 300,000 MHz. A preferred microwave frequency from the practical viewpoint is 2450 MHz. In the microwave region, the atomic or excited molecular species have a longer life time than those formed at radio frequencies and they can persist downstream quite a distance into the glowless region. This is an advantage from the analytical viewpoint, but it is also balanced by the more complicated and, therefore, more expensive electronic circuitry required. When using microwave gas excitation, the processing chamber is usually designed as a cavity, the generator is generally a magnetron type device and the electro-magnetic energy is conveyed by standard wave guides.
Irrespective of the gas excitation frequency, it has been observed that the presence of small amounts of aldehyde vapors in the gas plasma considerably reduces the time needed to kill sporulated and nonsporulated bacteria.
The invention is described further, by way of illustration, with reference to Figures 2 to 4 of the accompanying drawings, wherein:
Figure 2 is a schematic representation of an apparatus for sterilizing various hospital type disposals in a semi-continuous manner;
Figures 3 and 3A are sectional views of the sterilizing chamberof Figure 2; and
Figure 4 is a schematic representation of an alternative form of sterilizing chamber using microwave frequencies.
Referring to the drawings, Figure 2 illustrates the elements of a low temperature seeded plasma (referred to later as LTSP) system used for sterilizing in a semi-continuous manner various hospital type
disposals. The system comprises a tunnei-like processing chamber 1, having a door 2 at each end, only the door2 at the left-hand entrance side being shown. The disposables or non-disposables, for instance, plastic bottles of parenteral or ophthalmological solutions, are loaded in the cylindrical tunnel chamber by means of a conventional automatic rail conveyor type system (not shown). After loading, the front and rear doors 2 are closed automati caily by means of an electrically driven mechanical system 3.The loaded tunnel processing chamber 1 is then subjected to vacuum to provide a subatmospheric pressure therein by means of a vacuum line system 4 connected to a trap 5 and to a vacuum pump 6. The subatmospheric pressure is generally about 0.1 to 10 mm. of mercury inside the entire processing chamber 1.
The gas to be ionized then is delivered from a compressed gas line or bottle 7, the pressure and flow rate being regulated by pressure gauges and by a constant flow rate membrane or needle valve 8.
Aldehyde vapors are added to the gas flow from a container 9 by allowing the gas to bubble through liquid aldehyde and entrain the aldehyde vapors. A flowmeter 10 is inserted between the aldehydes container 9 and the inlet into the tunnel chamber 1. The mixture of gas and vapor is delivered through a hollow pipe line 11 with numerous small holes properly spaced for an even distrubtion into the tunnel chamber.
After evacuating most of the air in the tunnel chamber 1, the gas[vapor mixture is released in the
processing area. The gas/aldehyde vapor flow is adjusted according to the size and volume of the tunnel 1. The plasma formation is then initiated by proper impedance matching with inductive and capacitive controls, using an RF coil 12 which is part of an electrical circuit comprising a matching network 13, a powerwattmeter 14 and an RF generator 15 converting AC (alternating current) standard current into 13.56 MHz high frequency. The RF generator 15 used for sustaining a plasma discharge should be capable of withstanding large variations in the load impedance, and essentially comprises a DC (direct current) power supply, a crystal controlled RF oscillator and a solid state buffer amplifier.Final amplification is accomplished by a power amplifier designed around a power tube to accommodate large variations in load impedance. According to the type of installation, a single inductive coil extending over the entire tunnel length may be driven from a single power generator or a series of smaller coil sections may be operated from smaller modular type RF generators.
During RF excitation, continuous removal of gas plasma flow is effected over the reaction time period required to achieve complete sterilization, usually between 5 and 20 minutes. The RF excitation is then automatically shut down, the gas flow is interrupted and the vacuum pump is stopped. Air is introduced
automatically in the tunnel chamber 1 by a two-way valve 16. The two end doors are electro
mechanically opened and the samples container is automatically pulled out from the tunnel on a railing sliding system. The tunnel chamber 1 is then ready for sterilizing a new load. The entire sterilization cycle time generally takes between 10 and 30 minutes according to the type of processed material and power output level.
Figures 3 and 3a are more detailed sectional views of a longitudinal and lateral cross section, respectively, of a sterilizing tunnel type processing chamber 1, as shown in Figure 2. The tunnel 17 is of cylindrical shape around a main axis and essentially consists of two concentric cylindrical pipes 18 and 59 made of highly resistant inert material, such as, glass or a polymeric material, for example, a polysulfone, which are held by compression on end flanges with silicone type O-rings 20. After assembling the internal pipe 19 inside the external pipe 18, a hollow space ring 21 is created in which vacuum and subatmospheric pressure is provided by vacuum pump suction through bottom openings 22. To permit a subatmospheric atmosphere to be formed around the objects to be decontaminated, slots or holes 23 are perforated at the bottom of the internal cylinder 19.The objects to be sterilized, for example, plastic bottles 24 of parenteral solutions, are placed in a basket of parallelepipedic shape 25, which slides over a rail track 25 on roller bearing equipped wheels 27. At the beginning of the sterilizing cycle, the front and end doors 28 and 29 are automatically opened by an electrically operated device 30 which rotates the door 180 around the hinge 31. The front and end doors of the tunnel are generally made of a dark ultraviolet absorbing polymeric material to prevent the dangerous photon emission from escaping from the chamber while allowing its maximum intensity of gas plasma glow to be observed. The circular
O-rings 32 help to provide a good seal with the doors against the ingress of external air.The mixture of reactive gas and aldehyde vapor is introduced in the processing tunnel through a small pipe 33 with perforated holes 34. The small pipe for gas and vapor introduction enters the tunnel at one end and is positioned in the upper part of the internal pipe 19 to allow uniform gas diffusion over the entire tunnel length. In Figure 3, the RF inductive coil 35 is wrapped around the main external body of the processing tunnel 17.
Figure 4 illustrates another embodiment of the invention utilizing the microwave frequencies range from 100 MHzto 300,000 MHz. The microwave gas plasma sterilizer shown in Figure 4 consists of a metal housing 35 quite similar two those used in conventional microwave ovens. Located within the housing are the main components of the low temperature microwave gas plasma system, comprising a magnetron 36 which, by means of a transformer, rectifier, and magnetic field circuit contained in power pack 37, converts the AC current from the main power line 38 into microwave energy. The high power beam of microwave energy, typically at 2450
MHz, is contained in a wave guide 39 and directed against the blades 40 of a fan 41 which rotates at a slow RPM (revolutions per minute). The fan reflects the power beam, bouncing it off the walls, ceiling, back and bottom of the oven cavity 42. At the bottom of the oven cavity 42, a pyrex glass plate 43 transparent to microwaves is suspended approximately one inch above the metal bottom of the processing cavity. The instruments or material 44 to be surface sterilized are placed inside a gas tight sealed container 45 which is positioned in the oven cavity 42 and rests upon the glass plate 43. The container 45 may be constructed of any material which is transparent to microwave energy, including polymeric materials, such as, polypropylene, polyethylene, polystyrene and Teflon (trademark), carton board, paper or special glass composition. The container 45 is of parallelepipedic shape with an upper lid 46 also made of mocrowave transparent material.The lid 46 has two openings 47 and 48, each with a stopcock or valve 49 and 50 to allow the formation of the gas/aldehyde vapors mixture in a partial vacuum atmosphere of pressure between 0.1 and 10 mm of mercury. The container 45 contains two trays 51 which support the items 44 to be sterilized, for example, the illustrated plastic bottles for opthalmological solutions. The trays 51 are generally perforated to allow a more uniform diffusion of the ionized gas plasma. In the lower tray, a plastic cup 52 is inserted which contains the aldehyde solution 53 to be evaporated. Due to the thermal effect of microwaves, the aldehyde solution is gradually evaporated in the gas plasma when the microwave energy is switched on.The carrier gas to be ionized is delivered to container 45 through opening 47 from a gas bottle (not shown) into a pressure line 54 which includes a constant flow valve 55, a pressure gauge 56, and, if desired, a flowmeter. The low pressure vacuum needed to empty the loaded container 45 is created through opening 48 by vacuum line 57, which is connected to a trap 58 and to a vacuum pump 59.
A complete sterilizing cycle for the embodiment of
Figure 4 is as follows: filling the trays 51 with the equipment to be decontaminated, introduction of the aldehyde solution cup 52, air elimination by vacuum activation, introduction of the carrier gas, and switching on microwaves during the necessary time period, typically between 5 and 20 minutes, to main tain a continuous plasma flow. At the end of the exposure time, there is an automatic shut down of the microwave generator 41, the carrier gas flow is also stopped and the vacuum is broken through the two way valve 60. The door of the microwave oven cavity 35 is then opened and the container 45 is romeved after disconnecting the flexible tubings fastened to the stopcocks 49 and 50.The loaded container 45 can be maintained sterile, by the rapidly closing of the stopcocks 49 and 50, until there is a need to remove the decontaminated equipment under aseptic conditions. An entire sterilization cycle generally lasts between 10 and 30 minutes. At no time during processing does the surface temperature approach 100"C. No de-aeration of the decontaminated equipment is needed since the oxidizing plasma does not leave detectable traces of chemical on the treated surfaces.
The semicontinuous sterilizing process described above with respect to the equipment shown in Figures 2,3, 3A and 4 can be adapted to deliver sterile instruments inside packages if the package is punctured by a small hole giving access to the ionized and excited gas mixture. At the end ofthe sterilization, the package can be removed under white room conditions and a small sterile tape then applied to cover and seal the small hole. The sealing tape can be fastened manually or by an automatic machine.
The present invention can be applied to variable flow rates of different gases at different temperatures or multiple pressures. Further, the structural details of the described apparatuses, the dimensions and shapes of their members, such as tunnel or cavity sizes, and their arrangements, for example, introducing aldehyde vapors in microwave field through evaporation or by a bubbler in the carrier gas line, may be modified, and certain members may be replaced by other equivalent means, for example, RF coils may be replaced by capacitive plates and magnetrons may be replaced by klystrons or amplitron tubes, without departing from the scope of the invention.
The invention is illustrated by the following Examples. In these Examples, the sporicidal data presented was, in all instances, obtained according to the USDA (United States Department of Agriculture) approved fumigant sporicidal test method described in the Official Method of Analysis of the Association of Official Analytical Chemists (12th Ed., Nov. 1975).
Two types of highly resistant strains of the following species: B. subtilis (ATCC 19659) and Cl.
sporogenes (ATCC 3584), were used in the experiments. The spores carriers were silk suture loops (L) and porcelain cylinders (C) which carried a dry spores load of 106 to 109 9 microorganisms. The spores carriers were individually suspended from a thin cotton thread attached to the gas pipe at the top of the processing chamber.
There was also added at the bottom of the processing chamber several spore test strips wrapped inside an 1/2 inch thick surgical gauze. These control spore strips (American SterilizerCo. "SPORDI" (Trademark) were made of Bacillus subtilis (globigii) and Bacillus stearothermophilus. The subtilis strain was said to need a 60 minute exposure at 300 F for complete kill in dry heat while it required one hour and forty-five minutes at 130'to be destroyed in the presence of ethylene oxide gas concentration 600 mg, per liter, 50% relative humidity).In all the experiments, the vacuum dried, acid resistant AOAC strains of B. subtilis and Cl. sporogenes proved to be far more resistant than the SPORDI spores and, for the sake of simplicity, the results of the SPORDI "strips are not given in the data tables in the Examples.
Example 1
A series of experiments was conducted in a device
as illustrated in Figure 2. The carrier gases used to
form the plasma were pure oxygen, argon, and nit
rogen. The aldehyde vapors added to the carrier gas
were produced in a bubbler with solutions of the
following aldehydes: formalin (8% formaldehyde)
acetaldehyde, glyoxal, malonaldehyde, propional
dehyde, succinaldehyde, butyraldehyde, glutaral
dehyde, 2- hydroxyadipaldehyde, crotonaldehyde,
acrolein and benzaldehyde. The carrier gas flow rate
was between 80 cc. and 100 cc. per minute at room
temperature (about 20 to 25 C). The average inter nal pressure was 0.5 mm of mercury. The emission frequency was 13.56 MHz and the average power density output in the plasma processing chamber was about 0.015 watts per cubic centimeter.The minimum amount of aldehydes maintained in the continuous gas plasma flow was about 10 mg per liter.
Table 1 below shows the results of experiments assessing the influence of exposure time with the various low temperature aldehyde seeded plasmas.
Control experiments consisted both of the gas alone (no aldehyde) and of a non-oxidizing plasma (hydrogen gas) with formaldehyde or glutaraldehyde vapors. For each type of sporulated bacteria on the specific carrier (loop or cylinder), ten samples were used. In the tables, the results are shown on a "pass" or "fail" basis respectively indicated by the letter "P", which denotes no growth in any of 10 samples, and "F", which denotes 1 to 10 samples having bacterial growth after proper culturing and heat shocking. For the sake of clarity, all "fail" tests which preceeded the first "pass" tests were omitted since it is obvious that shorter exposure times correspond to "fail" tests. As may be seen from the results of Table 1, contact times between 10 and 30 minutes can provide satisfactory cidal action, the individual contact times depending on the type of aldehyde vapor utilized.
TABLE I
CARRIER GASES OXYGEN ARGON NITROGEN Exposure Time (min) 10 15 30 10 15 30 10 15 30 10 15 30 10 15 30 10 15 30 Type of Vaporised Aldehydes B. subtilis Cl. sporogenes B. subtilis Cl. sporogenes B. subtilis Cl. sporo.
in Carrier Gas LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC Formaldehyde PP PP PP PP PP PP Acetaldehyde PP FP PP PP FP PP FP PP FP PP Glyoxal PP PP PP PP PP FP PP Malonaldehyde PP PP PP PP PP PP Propionaldehyde PP PP PP FP PP PP FP PP Succinaldehyde PP FP PP PP FP PP FP PP FP PP Butyraldehyde PP PP PP PP PP FP PP Glutaraldehyde PP PP PP FP PP PP FP PP 2 Hydroxyadipaldehyde PP PP PP PP PP PP Acrolein PP PP PP PP PP PP Crotonaldehyde PP PP PP PP PP PP Benzaldehyde PP PP PP PP PP FP (Hydrogen- ) CONTROLS (Formaldehyde) FP FF FF FF FF FF Carrier Gas Alone PP FP PP FP FP PP (no aldehyde) Example 2
Utilizing the same experimental conditions as those of Example 1, except that the exposure time was maintained around 15 minutes while the power output was increased successively from 0.001 watts per cm3 of processing chamber to 0.015 to 0.1 watts per cm3, a further series of experiments was conducted.
As may be seen from the results set forth in Table
II below, no killing was achieved at the lowest power density, but excellent results were often obtained in the 0.015 to 0.1 watts per cm3 range. These results indicate the increased killing power which is attained by the addition of aldehyde traces in the gas plasma,
Oxygen appeared the best carrier among the gases used in this series of experiments. All "fail" tests which preceeded the first "pass" tests were omitted from Table II since it is obvious that lower power densities correspond to "fail" tests.
TABLE II
CARRIER CASES OXYGEN ARGON NITROGEN Power Density 1 15 100 1 15 100 1 15 100 1 15 100 1 15 100 1 15 100 (10-3 watts/cc) Type of vaporised aldehydes B. subtilis Cl.sporogenes B.subtilis Cl.sporogenes B.subtilis Cl.sporogenes in carrier gas LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC Formaldehyde PP PP PP PP PP PP Acetaldehyde PP FP PP FP PP FP PP FP PP Glyoxal PP PP PP PP PP PP Malonaldehyde FF PP FF PP FF PP FF PP FF PP FF PP Propionaldehyde PP PP PP FP PP PP FP PP Succinaldehyde PP PP PP PP PP PP Butyraldehyde PP PP PP PP PP FP PP Glutaraldehyde PP PP PP PP PP PP 2 Hydroxyadipaldehyde FF PP FF PP FF PP FF PP FF PP FF PP Acrolein PP PP PP PP PP PP Crotonaldehyde PP FF PP PP FF PP PP FF PP Benzaldehyde FF PP FF PP FF PP FF PP FF PP FF PP (Hydrogen
CONTROLS (Formaldehyde FP FF FF FF FF FF Carrier Gas Alone FF PP FP FF PP FF FP FF FP FF FP no aldehyde) Example 3
In a further series of experiments, the aldehydes were vaporized from 2% active ingredients solution and this corresponded roughly to a consumption of 15 cc. during a 15-minute run. However, when sampling the gas plasma, the concentration of aldehyde was found equal to 10 mg. per minute for a flow rate of 100 cc./min. This aldehyde concentration in the gas phase was roughly half the value to be expected from the vaporized aldehyde solution, indicating that approximately half the active aidehydes was deposited on the wall of the processing chamber.
The concentrations of aldehyde recited in Table Ill (below) are those observed in the gas plasma under normal operating conditions. As may be seen from the results, at the lower level of 0.1 mg./min., no increase in sporicidal activity was observed with any of the three gases used in the tests. At the 1 mg./min.
level, there were inconsistent results. At the 10 mg./min. level, most of the aldehydes boosted the sporicidal efficac/ of the gas plasma. At the 100 mg./min. level, all aldehydes showed an increased spores killing over when was observed with the aldehydes alone or with a non-oxidizing gas, such as, hydrogen loaded with aldehydes.
TABLE III
CARRIER GASES OXYGEN ARGON NITROGEN Vaporised Aldehydes 0.1 10 100 0.1 10 100 0.1 10 100 0.1 10 100 0.1 10 100 0.1 10 100 Flow Rate (mg/mm) Type of vaporised Aldehydes B.subtilis Cl.sporogenes B.subtilis Cl.sporogenes B.subtilis Cl.sporogenes in carrier gas LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC LC Formaldehyde PP PP PP PP PP PP Acetaldehyde PP FP PP FP PP FP PP FP PP Glyoxal PP PP PP PP PP PP Malonaldehyde FF PP FF PP FF PP FF PP FF PP FF PP Propionaldehyde PP PP PP FP PP PP FP PP Succinaldehyde PP PP PP PP PP PP Butyraldehyde PP PP PP PP PP FP PP Glutaraldehyde PP PP PP PP PP PP 2-Hydroxyadipaidehyde FF PP FF PP FF PP FF PP FF PP FF PP Acrolein PP PP PP PP PP PP Crotoneldehyde PP FF PP PP FF PP PP FF PP Benzaldehyde FF PP FF PP FF PP FF PP FF PP FF PP (Hydrogen-Glutar
CONTROLS(aldehyde FF FF FF FF FF FF Carrier Gas Alone FF FF FF FF FF FF (no aldehyde) Example 4
Table IV (below) shows the results observed when replacing a single aldehyde composition by a mixture of two different aldehydes or by a mixed formula containing an aldehyde with a non-aldehyde biocidal compound, i.e. phenol. A mixed composition gave the same results as a single aldehyde solution as long as the total content in aldehydes remained the same in the two formulas. The presence of the phenol did not affect the aldehyde efficacy as a sporicidal booster agent in the gas plasma.
Not reported on Table IV are a number of experi- ments conducted with various solutions of germicidal agents other than phenols. While maintaining the same concentration of aldehydes, there was added the following ingredients in equal concentration; halogen compounds, such as, chloroisocyanurates, for example, trichloro - S - triazinetrione and idophors, for example, PVP-iodine complex; inorganic salts, for example, selenium sulfide; an alcoholic solution of zinc undecylenate; ammonium quaternaries, such as, cetyl-pyridinium chloride; organo sulfurs, such as, methylenebis thiocyanate and nitrogen compounds of fatty amines, such as N-alkyl trimethylene diamine. In no case was there detected a synergistic effect due to the presence of these agents in the vapor phase.
There was noted, however, a slight increase in activity (additive effects) each time the plasma vaporization led to the dissociation of the chemical salt with a release of a halogen. The strong corrosive effect of ionized halogens was also observed and this renders impractical the use of such chemicals in a seeded low temperature plasma gas.
TABLE IV
CARRIER GASES OXYGEN ARGON NITROGEN Type of aldehydes mixture B.subtilis Cl.sporogenes B.subtilis Cl.sporogenes B.subtilis Cl.sporogenes (2% total content in aldehydes) L C L C L C L C L C L C Formaldehyde + Glutaraidehyde P P P P P P P P P P P P Succinaldehyde + Formaldehyde P P P P P P P P P P P P Glutaraldehyde + Phenol P P P P P P P P P P P P Butyraldehyde + Glutaraldehyde P P P P P P P P P P P P Formaldehyde + Acetaldehyde P P P P P P P P P P P P CONTROLS Carrier Gas Alone F F F F F F F F F F F F (no aldehydes) Example 5
A further set of experiments was conducted in the
apparatus of Figure 4. Since these experiments were conducted at higher frequencies than is the case for
Examples 1 to 4, the microwave glow discharge was
more uniform inside an experimental polysulfone container.The gas plasma pressure (2mm. of mercury) was slightly higher than in previous tests because microwave discharges are more difficult to initiate and to sustain at low pressures (~ 1 mm. of mercury) than DC or RF discharges.
Due to the higher longevity and efficacy of free radicals and ionized species in a microwave gas plasma, the contact time was reduced to 10 minutes.
The plastic-polysulfone container transparent to microwaves had the following dimensions: 15 x 35 x 25 cms. (volume 16.37 liters). The average density of the electromagnetic energy inside the resonantcavity of about 0.02 watts/cc was tuned at the nominal frequency of 2540 MHz (+ 25 MHz). The gas flow rate was adjusted between 900 cc. and 1000 cc. per minute which corresponded to an average aldehyde content of 18 mg./min. in the plasma phase. During the 10 minutes processing, around 18 cc. of each aldehyde solution of 2% concentration by weight was evaporated. This corresponded also to roughly twice the amount actually present for reaction in the gas plasma.
One may be seen from the results set forth in
Table V, an increase in sporicidal efficacy results from the seeding of the small amount of aromatic,
heterocyclic, saturated or unsaturated aldehydes in the electromagnetic continuous gas plasma discharge. When vaporizing furfural, the concentration of this chemical in the oxygen flow stream was 0.0018% by volume, since this chemical has a lower explosive limit in air of 2.1% by volume. The 2% aqueous solution was maintained at all times during evaporation below the open cup flash point of this aldehyde which is around 68"C. Besides benzaldehyde, other aromatic aldehydes, such as, thiophenaldehyde, and pyridine - 2 - aldehyde have qualitatively shown the same behavior.
TABLE V
CARRIER GASES OXYGEN ARGON NITROGEN Type of Vaporized B.subtilis Cl.sporogenes B.subtilis Cl.sporogenes B.subtilis Cl.sporogenes Aldehydes LC LC LC LC LC LC in carrier gas Formaldehyde PP PP PP PP PP PP Acetaldehyde PP PP PP PP PP PP Glyoxal PP PP PP PP PP PP Malonaldehyde PP PP PP PP PP PP Propionaldehyde PP PP PP PP PP PP Succinaldehyde PP PP PP PP PP PP Butyraldehyde PP PP PP PP PP PP Glutaraldehyde PP PP PP PP PP PP 2-Hydroxyadipaldehyde PP PP PP PP PP PP Acrolein PP PP PP PP PP PP Crotonaldehyde PP PP PP PP PP PP Benzaldehyde PP PP PP PP PP PP Furfural PP PP PP PP PP PP CONTROLS Carrier Gas FP FF FP FF FF FF Alone (no aldehydes) In summary of this disclosure, the present invention provides a plasma gas sterilization method having substantial advantages over prior gas phase sterilization procedures. Modifications are possible within the scope of this invention.
Claims (17)
1. A method of sterilizing a surface comprising contacting the surface with a low temperature gas plasma containing at least 10 mg/l of an aldehyde under subatmospheric pressure.
2. A method as claimed in claim 1 in which the aldehyde is an aromatic, heterocyclic, or saturated acyclic or unsaturated acyclic aldehyde.
3. A method as claimed in claim 1 or 2, in which the aldehyde is formaldehyde, acetaldehyde, glyoxal, malonaldehyde, propionaldehyde, succinaldehyde, butyraldehyde, glutaraldehyde, 2 - hydroxyadipaldehyde, acrolein, crotonaldehyde, benzaldehyde or furfural.
4. A method as claimed in any one of claims 1 to 3, in which the pressure of the gas plasma is 0.1 to 10 mm of mercury.
5. A method as claimed in claim 1 or 2 in which the gas plasma is produced by electromagnetic excitation of oxygen, argon, helium, nitrogen, carbon dioxide, nitrogen oxide or a mixture of two or more of such gases.
6. A method as claimed in any one of claims 1 to 5 in which the gas plasma is produced by electromagnetic discharges in the 1 to 100 MHz radio frequency region.
7. A method as claimed in any one of claims 1 to 5 in which the gas plasma is produced by gaseous electromagnetic discharges in the 100 to 300,000
MHz microwave range.
8. A method as claimed In claim 6 or 7 in which the gas plasma is confined inside a fluid-tight chamber and the electromagnetic field density in the chamber is at least 0.001 watts per cubic centimeter.
9. A method as claimed in any one of claims 1 to 8, in which the aldehyde is introduced to a continuously-produced gas plasma stream in a carrier gas flow upstream of the sterilization location.
10. A method as claimed in any one of claims 1 to 8 in which the aldehyde is introduced to a continuously-produced gas plasma stream in a plasma forming chamber in which the sterilization is also effected.
11. A method as claimed in any one of claims 1 to 10 in which the gas plasma also contains a vaporized biocidal agent.
12. A method as claimed in claim 11, in which the biocidal agent is phenol, halogen, inorganic or organic metal salt, an organosulfur or nitrogen compound, or a mixture of two or more of such agents.
13. A method as claimed in claim 11 or 12, in which the biocidal agent is present in the gas plasma in an amount of at least 10 mg/l.
14. A method of sterilizing a surface substantially as hereinbefore described with reference to any one ofthe Examples.
15. A method of sterilizing a surface substantially as hereinbefore described with reference to, and as illustrated in, Figures 2 to 3 of the accompanying drawings.
16. A method of sterilizing a surface substantially as hereinbefore described with reference to, and as illustrated in, Figure 4 of the accompanying drawings.
17. Asterile surface whenever produced buy a method as claimed in any one of claims 1 to 16.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8000096A GB2066076B (en) | 1980-01-02 | 1980-01-02 | Sterilizing with gas plasmas and aldehydes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8000096A GB2066076B (en) | 1980-01-02 | 1980-01-02 | Sterilizing with gas plasmas and aldehydes |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2066076A true GB2066076A (en) | 1981-07-08 |
GB2066076B GB2066076B (en) | 1983-11-16 |
Family
ID=10510410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8000096A Expired GB2066076B (en) | 1980-01-02 | 1980-01-02 | Sterilizing with gas plasmas and aldehydes |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2066076B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0303682A4 (en) * | 1987-02-25 | 1991-10-02 | Adir Jacob | Process for dry sterilization of medical devices and materials |
US5422068A (en) * | 1994-01-05 | 1995-06-06 | Shalaby; Shalaby W. | Radiochemical sterilization |
RU2157703C2 (en) * | 1994-10-11 | 2000-10-20 | Этикон, Инк. | Method for applying vacuum plasma sterilization of products |
GB2371986A (en) * | 2001-02-09 | 2002-08-14 | Jacques Protic | Sterilisation process |
EP1236396A1 (en) * | 1998-12-24 | 2002-09-04 | Reckitt Benckiser (UK) LIMITED | Apparatus for dispersing a volatile composition |
WO2003075965A1 (en) * | 2002-03-08 | 2003-09-18 | Rüdiger Haaga GmbH | Device for sterilizing objects |
-
1980
- 1980-01-02 GB GB8000096A patent/GB2066076B/en not_active Expired
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0303682A4 (en) * | 1987-02-25 | 1991-10-02 | Adir Jacob | Process for dry sterilization of medical devices and materials |
EP0596862A3 (en) * | 1987-02-25 | 1996-02-07 | Adir Jacob | Process and apparatus for dry sterilization of medical devices and materials. |
EP0596861A3 (en) * | 1987-02-25 | 1996-02-07 | Adir Jacob | Process and apparatus for dry sterilization of medical devices and materials. |
US5422068A (en) * | 1994-01-05 | 1995-06-06 | Shalaby; Shalaby W. | Radiochemical sterilization |
RU2157703C2 (en) * | 1994-10-11 | 2000-10-20 | Этикон, Инк. | Method for applying vacuum plasma sterilization of products |
EP1236396A1 (en) * | 1998-12-24 | 2002-09-04 | Reckitt Benckiser (UK) LIMITED | Apparatus for dispersing a volatile composition |
US6701663B1 (en) | 1998-12-24 | 2004-03-09 | Reckitt Benckiser (Uk) Limited | Method and apparatus for dispersing a volatile composition |
US6877271B2 (en) | 1998-12-24 | 2005-04-12 | Reckitt Benckiser (Uk) Limited | Method and apparatus for dispersing a volatile composition |
GB2371986A (en) * | 2001-02-09 | 2002-08-14 | Jacques Protic | Sterilisation process |
WO2003075965A1 (en) * | 2002-03-08 | 2003-09-18 | Rüdiger Haaga GmbH | Device for sterilizing objects |
GB2401049A (en) * | 2002-03-08 | 2004-11-03 | Haaga Gmbh Rudiger | Device for sterilizing objects |
GB2401049B (en) * | 2002-03-08 | 2005-08-24 | Haaga Gmbh Rudiger | Arrangement for sterilizing objects |
US7544334B2 (en) | 2002-03-08 | 2009-06-09 | Ruediger Haaga Gmbh | Device for sterilizing objects |
CN100584387C (en) * | 2002-03-08 | 2010-01-27 | 鲁迪格哈加有限责任公司 | Item sterilization device |
Also Published As
Publication number | Publication date |
---|---|
GB2066076B (en) | 1983-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4207286A (en) | Seeded gas plasma sterilization method | |
JP2780228B2 (en) | Plasma sterilization method and apparatus by pulsed sterilizing agent treatment | |
KR100874681B1 (en) | Sterilization method using pretreatment using hydrogen peroxide | |
US6261518B1 (en) | Process and apparatus for plasma sterilizing with pulsed antimicrobial agent treatment | |
US6036918A (en) | Vapor sterilization | |
US20040022673A1 (en) | Sterilisation process and apparatus therefor | |
US3753651A (en) | Method and apparatus for surface sterilization | |
US5084239A (en) | Plasma sterilizing process with pulsed antimicrobial agent treatment | |
EP1558295B1 (en) | Plasma treatment module-equipped sterilization apparatus and sterilization method | |
WO2001070281A1 (en) | Plasma disinfection system | |
EP0835141A1 (en) | Plasma water vapor sterilizer and method | |
IE62133B1 (en) | Sterilization | |
US6039921A (en) | Liquid phase disinfection/sterilization with microwave energy | |
EP0456135A2 (en) | Sterilizing with hydrogen peroxide and plasma | |
GB2066076A (en) | Sterilizing with gas plasmas and aldehydes | |
CA1104322A (en) | Seeded gas plasma sterilization method | |
JPS609453B2 (en) | Sterilization using seeded gas plasma | |
EP0456134A2 (en) | Sterilizing with peracid and plasma | |
DE3000709C2 (en) | Method for sterilizing a surface | |
GB2371986A (en) | Sterilisation process | |
FR2473889A1 (en) | Sterilisation of surfaces esp. hospital equipment - by application of a low temp. gas plasma contg. an aldehyde under sub-atmospheric pressure | |
SE426288B (en) | Method for sterilizing a surface by contact with gas plasma containing aldehydes | |
Lambert | Radiation sterilization | |
NL8000253A (en) | Sterilisation of surfaces esp. hospital equipment - by application of a low temp. gas plasma contg. an aldehyde under sub-atmospheric pressure | |
CH640417A5 (en) | Method for sterilisation by means of a gas plasma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19940102 |